Anti-Embolism Stockings Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global anti-embolism stockings market is poised for significant growth, with market size projected to increase from US$ 765 million in 2025 to US$ 1.15 billion by 2032. This expansion is expected to occur at a steady CAGR of 6.0% from 2025 to 2032. Anti-embolism stockings play a vital role in preventing blood clots, especially in immobile patients, and are becoming increasingly popular due to rising awareness of venous thromboembolism (VTE) and its associated risks.

Market Insights

Anti-embolism stockings are specialized medical garments designed to enhance blood circulation, reduce vein dilation, and support valvular function in the lower limbs. Unlike standard compression stockings, they are specifically recommended for bedridden or post-operative patients who are at risk of developing deep vein thrombosis (DVT). Calf-length anti-embolism stockings continue to dominate the market due to their comfort, affordability, and safety, accounting for the majority share of sales globally.

Men represent a larger consumer base, with this demographic accounting for a higher share of product usage. This trend is largely attributed to higher obesity rates among men in various regions, which increases the risk of DVT and other vascular conditions.

Market Drivers

A major factor contributing to the market growth is the rising geriatric population globally. According to the World Health Organization, the proportion of people over 60 years of age is steadily increasing, driving demand for vascular support products. This demographic shift, coupled with an increasing prevalence of chronic conditions such as cancer, cardiovascular disorders, and diabetes, is accelerating the need for effective preventive measures like anti-embolism stockings.

In addition, the rising adoption of sedentary lifestyles and associated health issues such as obesity and poor circulation are further fueling demand. With obesity becoming a global health concern across income levels, especially in urban areas, the role of anti-embolism stockings in reducing DVT risk has become more prominent.

Business Opportunity

Technological advancements in textile and wearable medical devices are creating new growth avenues for manufacturers. Companies are focusing on integrating smart sensors into compression garments to enhance patient monitoring and therapeutic outcomes. Additionally, non-pneumatic compression garments are being developed for specialized use, including managing intradialytic hypotension in patients undergoing dialysis.

Although not yet a fully defined market, the use of anti-embolism stockings in cancer care is showing potential due to their affordability and ease of application, especially in outpatient settings. The opportunity to cater to cancer patients with preventive vascular products could unlock a new market segment for leading manufacturers.

Regional Analysis

North America leads the global anti-embolism stockings market, with the United States dominating regional revenue due to high awareness, advanced healthcare infrastructure, and a rising incidence of venous thromboembolism. Factors such as increased online availability and health-conscious consumers are supporting market expansion in the country.

Europe remains another significant contributor, with the United Kingdom showing strong growth driven by heightened public awareness and developments in orthopedic and vascular health technologies. Online marketing efforts and increasing consumer education are propelling adoption rates in the region.

India is emerging as a lucrative market in South Asia. The growing number of DVT cases, combined with improved healthcare access and an aging population, presents ample opportunities for manufacturers. Increased urbanization and sedentary lifestyles are also contributing to demand growth across metropolitan regions.

Key Players

The anti-embolism stockings market is highly competitive, with several global and regional players striving to enhance their market share. Leading companies are expanding product portfolios, leveraging online distribution channels, and entering into strategic acquisitions.

Prominent players in the market include:

• Medtronic (Covidien)
• Sigvaris
• 3M
• Juzo
• Bauerfeind AG
• Thuasne SAS
• BSN Medical
• Pretty Legs Hosiery
• Paul Hartmann
• Cizeta Medicali
• Salzmann-Group
• Gloria Med
• Zhende Medical Group
• Maizi
• TOKO
• Okamoto Corporation
• Zhejiang Sameri

Recent strategic developments include Thuasne SAS acquiring Knit-Rite Inc. and its Therafirm division in 2021, and 3M acquiring Acelity Inc. and its subsidiaries in 2019 to strengthen their global footprint and expand their product offerings in compression therapy.

Segmentation

By Product Type

• Calf-length
• Thigh-length

By Demography

• Men
• Women

By End User

• Ambulatory Patients
• Post-operative Patients
• Pregnant Women
• Others

By Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

This product will be delivered within 1-3 business days.